Evidence map›Paper›PMID 39165356›Full record

ArticleFrontiers in immunology2024

Causal associations between

Xin Wang, Deming Jiang, Xiao Zhang, Ran Wang, Fengyi Yang, Chunrong Xie

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. The microbiota-proteostasis axis: implications in neurodegenerative diseases.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026
    Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xin Wang *Department of Neurology, Beijing Huairou Hospital of Traditional Chinese Medicine, Beijing, China.
Deming Jiang *Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Xiao ZhangDepartment of Neurology, Beijing Huairou Hospital of Traditional Chinese Medicine, Beijing, China.
Ran WangDepartment of Neurology, Beijing Huairou Hospital of Traditional Chinese Medicine, Beijing, China.
Fengyi YangDepartment of Neurology, Beijing Huairou Hospital of Traditional Chinese Medicine, Beijing, China.
Chunrong XieDepartment of Neurology, Beijing Huairou Hospital of Traditional Chinese Medicine, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Increasing evidence suggests an association between Objective: To investigate the causal relationship between HP infection and PD risk, PD symptoms, and secondary parkinsonism, we conducted two-sample Mendelian randomization (MR). Methods: We obtained summary data from genome-wide association studies for seven different antibodies specific to HP proteins and five PD-related phenotypes. The inverse-variance weighted (IVW), weighted median, weighted mode, and MR-Egger methods were used to assess the causal relationships. Sensitivity analyses were performed to examine the stability of the MR results and reverse MR analysis was conducted to evaluate the presence of reverse causality. Results: Genetically predicted HP antibodies were not causally associated with an increased risk of PD. However, HP cytotoxin-associated gene-A (CagA) and outer membrane protein (OMP) antibody level were causally associated with PD motor subtype (tremor to postural instability/gait difficulty score ratio; Conclusions: Our findings indicate that HP infection does not increase the risk of PD, but contributes to PD motor and cognitive symptoms. Different types of HP antibodies affect different symptoms of PD. Eradication of HP infection may help modulate and improve symptoms in PD patients.

Indexed as

Antibodies, BacterialGenome-Wide Association StudyHelicobacter InfectionsHelicobacter pyloriMendelian Randomization AnalysisParkinson DiseaseHumansRisk FactorsAntibodies, BacterialHelicobacter pyloriMendelian randomizationmotor subtypeParkinson’s diseasesymptom

Identifiers

PMID39165356
PMCPMC11333313

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.